tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market
ATOS
Atossa Therapeutics
RESEARCH TOOLSreports

Atossa Therapeutics (ATOS) Stock News & Sentiment

Compare
2,519 Followers
Atossa Therapeutics Sets 15-for-1 Reverse Stock Split
Premium
Company Announcements
Atossa Therapeutics Sets 15-for-1 Reverse Stock Split
3d ago
8K
ATOS
Atossa Therapeutics outlines strategy for lead (Z)-Endoxifen program
Premium
Company Announcements
Atossa Therapeutics outlines strategy for lead (Z)-Endoxifen program
20d ago
8K
ATOS
Atossa Wins FDA Clearance to Advance (Z)-Endoxifen Trial
Premium
Company Announcements
Atossa Wins FDA Clearance to Advance (Z)-Endoxifen Trial
23d ago
8K
ATOS
Atossa Therapeutics: Buy Rating on Promising DMD Advancements and Strategic Growth Potential
Premium
Ratings
Atossa Therapeutics: Buy Rating on Promising DMD Advancements and Strategic Growth Potential
1M ago
ATOS
Promising Clinical Trial Results of Z-endoxifen Support Buy Rating for Atossa Therapeutics
Premium
Ratings
Promising Clinical Trial Results of Z-endoxifen Support Buy Rating for Atossa Therapeutics
1M ago
ATOS
Strategic Advancements and Regulatory Progress Boost Atossa Therapeutics’ Outlook
Premium
Ratings
Strategic Advancements and Regulatory Progress Boost Atossa Therapeutics’ Outlook
2M ago
ATOS
Atossa Completes FDA Meeting on Regulatory Strategies
Premium
Company Announcements
Atossa Completes FDA Meeting on Regulatory Strategies
2M ago
8K
ATOS
More ATOS News >

ATOS News on the Web

Atossa Therapeutics Sets 15-for-1 Reverse Stock Split
TipRanks News
Bearish
Analysts Are Bullish on Top Healthcare Stocks: Opko Health (OPK), Achieve Life Sciences (ACHV)
TipRanks News
Bullish
Atossa Secures FDA Orphan Drug Designation For (Z)-Endoxifen In Duchenne Muscular Dystrophy
rttnews
Bullish
Atossa Therapeutics: FDA grants orphan designation to (Z)-endoxifen
TipRanks News
Bullish
FDA grants Atossa Therapeutics orphan drug designation for (Z)-endoxifen
TipRanks News
Bullish
Why Atossa Therapeutics, Inc.’s (ATOS) Stock Is Up 5.19%
AAII
Neutral
Atossa Therapeutics outlines strategy for lead (Z)-Endoxifen program
TipRanks News
Bearish
Atossa Wins FDA Clearance to Advance (Z)-Endoxifen Trial
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ATOS
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week0%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATOS’s Media Buzz Sentiment?
1 articles about ATOS were published this week. In an average week, 2.5 articles are published.
    What is ATOS’s weekly average amount of articles?
    In an average week, 2.5 articles about ATOS are published.
      What is ATOS’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      CRDFCardiff Oncology
      VREOFVireo Growth
      CBLControl Bionics Ltd.
      HCAHCA Healthcare
      CYCCyclopharm Limited
      Showing the stocks with the most bullish news sentiment over the past week